{"54I.SG": {"short_name": "Instem PLC Registered Shares LS", "long_name": "Instem plc", "summary": "Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource EDC system for early phase clinical trials; Ames Study Manager, an integrated suite of software for conducting the Bacterial Reverse Mutation Test; Toxicology Resource Planning, a toxicology solution; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; Cyto Study Manager, a data acquisition and reporting solution; lead scope for computational toxicology; Logbook, a repository for information; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies. The company also provides Samarind RMS to manage medical product information; Sorcerer Colony Counter for automatic plate counter; SEND Explorer, a web-based application with optional data warehousing capabilities; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; and SENDTrial, a full Web based solution that can be accessed through a subscription. In addition, it offers data management, cloud, safety assessment, regulatory information management, solution deployment, and validation services. Further, the company provides software solutions for extracting intelligence from research and development related healthcare data; and develops, manufactures, and supplies software and hardware products for in vitro study data collection and study management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "STU", "market": "dr_market", "country": "United Kingdom", "city": "Stone"}, "CRW.L": {"short_name": "CRANEWARE PLC ORD 1P", "long_name": "Craneware plc", "summary": "Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; interface scripting module, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; Patient Charge Estimator to simplify the process of providing patient bill estimates for inpatient and outpatient services; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Edinburgh"}, "DOC.AX": {"short_name": "DOCTORCARE CDI 1:1", "long_name": "Doctor Care Anywhere Group PLC", "summary": "Doctor Care Anywhere Group PLC operates as a doctor-founded digital healthcare company. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, and service improvements. The company provides treatments for allergies, bites and stings, cold and flu conditions, headaches and migraines, joint pains, lifestyle support, mental health conditions, sexual health problems, skin conditions, and stomach and digestive problems. It serves corporate, and small and medium-sized enterprise clients in the United Kingdom. The company was founded in 2013 and is based in London, United Kingdom.", "currency": "AUD", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "ASX", "market": "au_market", "country": "United Kingdom", "city": "London"}, "DSH.F": {"short_name": "SENSYNE HEALTH LT  LS-,1", "long_name": "Sensyne Health plc", "summary": "Sensyne Health plc, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States. Its products include CVm-Health, a web-based application for coronavirus self-monitoring; DBm-Health, which helps individuals monitor their blood glucose levels and share their readings with health care professionals; GDm-Health, a prescribed digital therapeutic for remote management of diabetes in pregnancy; and BPm-Health that allows pregnant women to self-monitor blood pressure during pregnancy. The company's products also include SEND, an early warning system for monitoring patient vital signs in hospital; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; and Support-HF, a prescribed digital therapeutic for monitoring heart failure at home. Sensyne Health has strategic research alliance with Bayer to develop new treatments using clinical artificial intelligence; research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Milton Keynes University Hospital NHS Foundation Trust to enable the ethical application of clinical artificial intelligence research to improve patient care and research into new medicines; collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Hampshire Hospitals NHS Foundation Trust. Sensyne Health plc was incorporated in 2018 and is based in Oxford, the United Kingdom.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "FRA", "market": "dr_market", "country": "United Kingdom", "city": "Oxford"}, "EMIS.L": {"short_name": "EMIS GROUP PLC ORD 1P", "long_name": "EMIS Group plc", "summary": "EMIS Group plc, through its subsidiaries, provides healthcare software, information technology, and related services for healthcare professionals in the United Kingdom. It operates in two segments: EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to NHS markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on B2B technology sector in the healthcare market, such as management of medicines, partner businesses, patient-facing services, and healthcare block chain. The company also supplies technologies; provides patient-centric medical and wellbeing information and related transactional services under the patient brand; offers specialist ICT infrastructure, hardware, and engineering services, as well as non-clinical software under the egton brand; and operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content and Patient Access, which enables people to book appointments for healthcare services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Leeds"}, "FDBK.L": {"short_name": "FEEDBACK PLC ORD 0.25P", "long_name": "Feedback plc", "summary": "Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. Its products include TexRAD, a software tool, which extracts and quantifies texture features in radiological images, assisting research into all tumor types, as well as uncovers biomarkers in medical images; and TexRAD Lung for the analysis of lung cancer for clinical use in the European Union. The company also offers Cadran image platform that provides hospitals and research institutes with a comprehensive picture archiving communication system for medical images, as well as equips users with a platform for image handling from all imaging modalities, such as CT and PET scanners; and Bleepa, which combines secure instant messaging with the ability to see clinical grade medical images, including X-rays, and CT and MRI scans using portable devices, such as smartphones or tablets. Feedback plc was founded in 1958 and is headquartered in London, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "London"}, "INHC.L": {"short_name": "INDUCTION HEALTHCARE GROUP PLC ", "long_name": "Induction Healthcare Group PLC", "summary": "Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, rest of Europe, the United States, and internationally. It offers Induction Switch, a communication and sharing platform that enables healthcare professionals to connect and collaborate securely with the people they need within a complex clinical environment; MicroGuide, a platform to create, edit, and publish structured and governance-controlled guidance and policies; Zesty, a digital platform that allows patients to book appointments, read appointment and clinical letters, store a local copy of clinical record, and provide data to care teams remotely; and HealthStream that reads and writes demographic, appointment, and clinical record data. The company was incorporated in 2019 and is based in London, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "London"}, "INS.L": {"short_name": "INSTEM PLC ORD 10P", "long_name": "Instem plc", "summary": "Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource EDC system for early phase clinical trials; Ames Study Manager, an integrated suite of software for conducting the Bacterial Reverse Mutation Test; Toxicology Resource Planning, a toxicology solution; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; Cyto Study Manager, a data acquisition and reporting solution; lead scope for computational toxicology; Logbook, a repository for information; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies. The company also provides Samarind RMS to manage medical product information; Sorcerer Colony Counter for automatic plate counter; SEND Explorer, a web-based application with optional data warehousing capabilities; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; and SENDTrial, a full Web based solution that can be accessed through a subscription. In addition, it offers data management, cloud, safety assessment, regulatory information management, solution deployment, and validation services. Further, the company provides software solutions for extracting intelligence from research and development related healthcare data; and develops, manufactures, and supplies software and hardware products for in vitro study data collection and study management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Stone"}, "SENS.L": {"short_name": "SENSYNE HEALTH PLC ORD 10P", "long_name": "Sensyne Health plc", "summary": "Sensyne Health plc, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States. Its products include CVm-Health, a web-based application for coronavirus self-monitoring; DBm-Health, which helps individuals monitor their blood glucose levels and share their readings with health care professionals; GDm-Health, a prescribed digital therapeutic for remote management of diabetes in pregnancy; and BPm-Health that allows pregnant women to self-monitor blood pressure during pregnancy. The company's products also include SEND, an early warning system for monitoring patient vital signs in hospital; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; and Support-HF, a prescribed digital therapeutic for monitoring heart failure at home. Sensyne Health has strategic research alliance with Bayer to develop new treatments using clinical artificial intelligence; research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Milton Keynes University Hospital NHS Foundation Trust to enable the ethical application of clinical artificial intelligence research to improve patient care and research into new medicines; collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Hampshire Hospitals NHS Foundation Trust. Sensyne Health plc was incorporated in 2018 and is based in Oxford, the United Kingdom.", "currency": "GBp", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "LSE", "market": "gb_market", "country": "United Kingdom", "city": "Oxford"}, "SSYNF": {"short_name": "SENSYNE HEALTH PLC", "long_name": "Sensyne Health plc", "summary": "Sensyne Health plc, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States. Its products include CVm-Health, a web-based application for coronavirus self-monitoring; DBm-Health, which helps individuals monitor their blood glucose levels and share their readings with health care professionals; GDm-Health, a prescribed digital therapeutic for remote management of diabetes in pregnancy; and BPm-Health that allows pregnant women to self-monitor blood pressure during pregnancy. The company's products also include SEND, an early warning system for monitoring patient vital signs in hospital; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; and Support-HF, a prescribed digital therapeutic for monitoring heart failure at home. Sensyne Health has strategic research alliance with Bayer to develop new treatments using clinical artificial intelligence; research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Milton Keynes University Hospital NHS Foundation Trust to enable the ethical application of clinical artificial intelligence research to improve patient care and research into new medicines; collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; and strategic research agreement with Hampshire Hospitals NHS Foundation Trust. Sensyne Health plc was incorporated in 2018 and is based in Oxford, the United Kingdom.", "currency": "USD", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "PNK", "market": "us_market", "country": "United Kingdom", "city": "Oxford"}}